We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Excellent Outlook for Aortic Dissection Survivors

By HospiMedica staff writers
Posted on 23 Aug 2006
A new study found that 90% of patients who survive emergency surgery and hospitalization for aortic dissection will still be alive three years later. More...


Researchers at the Cardiovascular Center of the University of Michigan (U-M, Ann Arbor, USA) examined data from 303 patients--treated at 21 medical centers in 11 countries--listed in the International Registry of Aortic Dissection (IRAD). The patients were treated in the late 1990s and early 2000s for the most serious form of aortic dissection, called type A, which occurs in the upper part of the aorta near the heart. The study found that 90% of patients who survive emergency surgery and hospitalization for its most serious form will still be alive three years later; those without pre-existing heart and blood vessel problems were even more likely to survive. The findings were published in a supplement to the July 4, 2006, issue of the journal Circulation.

The biggest impact on survival rates was made by underlying health problems--such as hypertension (72%), atherosclerosis (25%), and previous cardiovascular surgery (13%)--and not any aspect of in-hospital complications. In fact, patients who had atherosclerosis or previous cardiovascular surgery had twice the risk of dying in the three-year follow-up period as patients without these characteristics.

Because aortic dissection is rare and its symptoms can mimic those of a heart attack, it is often not diagnosed or treated quickly, contributing to a 30% in-hospital death rate that includes a 25% risk of death during surgery. The IRAD team is working to improve the screening tools that might be used to determine who is at high risk of an aortic dissection. Currently, people with Marfan syndrome, connective tissue disorders, long-term blood pressure problems, and some other conditions are known to have an elevated risk.

"Clearly, this is one of those diseases where if you catch it early you can save lives in the hospital, and with successful surgery your outlook after discharge can look quite good,” said lead author Thomas Tsai, M.D., a cardiovascular research fellow at the U-M Medical School. "Of course, those who do survive will have a diagnosis for life of aortic disease, and will need medication and aggressive monitoring of their aorta.”



Related Links:
University of Michigan

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.